Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis

Condition:   Lyme Borreliosis Interventions:   Biological: VLA15;   Biological: Placebo Sponsor:   Valneva Austria GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials